Valuation eFFECTOR Therapeutics, Inc. Boerse Muenchen

Stocks

Real-time Boerse Muenchen			5-day change	1st Jan Change
- ^EUR	-.--%		-.--%	-

10/09/24	Tyra Biosciences Names Doug Warner Chief Medical Officer	MT
07/07/24	EFFECTOR Therapeutics, Inc.(OTCPK:EFTR) dropped from S&P TMI Index	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023
Market Cap ¹	334.3	17.91	30.2
Change	-	-94.64%	68.61%
Enterprise Value (EV) ¹	304.6	11.88	32.38
Change	-	-96.1%	172.45%
P/E	18.8x	-0.78x	-0.71x
PBR	19.3x	4.58x	-6.01x
PEG	0x	0x	-0x
Capitalization / Revenue	233,760,757x	5,041,796x	-
EV / Revenue	-	-	-
EV / EBITDA	-9.56x	-0.37x	-0.96x
EV / EBIT	-9.55x	-0.37x	-0.96x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	11	-13.76	-16.37
Distribution rate	-	-	-
Net sales	1.43	3.553	-
EBITDA ¹	-31.87	-32.35	-33.73
EBIT ¹	-31.9	-32.4	-33.84
Net income ¹	15.8	-22.66	-35.81
Net Debt ¹	-29.67	-6.029	2.175
Reference price ²	207.000000	10.690000	11.685000
Nbr of stocks (in thousands)	1,615	1,676	2,585
Announcement Date	16/03/22	08/03/23	26/03/24

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
WUXI APPTEC CO., LTD.	20.59x	7.25x	14.66x	1.42%	69.54B
ARGENX SE	36.89x	9.62x	29.41x	0.04%	64.97B
WUXI BIOLOGICS (CAYMAN) INC.	30.69x	6.58x	17.2x	-.--%	26.51B
INSMED INCORPORATED	-72.56x	13.98x	-67.43x	-.--%	25.89B
BIONTECH SE	-15.61x	5.94x	-7.46x	-.--%	25.64B
PHARMAESSENTIA CORPORATION	58.27x	21.67x	43.95x	0.26%	20.22B
GENMAB A/S	27.27x	5.11x	16.98x	-.--%	19.98B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	1415.29x	39.34x	858.54x	-.--%	15.69B
EXELIXIS, INC.	16.84x	5x	11.66x	-.--%	13.49B
Average	168.63x	12.72x	101.95x	0.19%	31.33B
Weighted average by Cap.	94.04x	10.79x	57.82x	0.38%